Our objective is to introduce a fresh perspective on ultrasonographic endometrial assessment, unveiling an innovative classification framework that intricately elucidates its structural attributes.
By illuminating this novel viewpoint, we:
introduce a Artificial Intelligence model based on neural network that implement it.
Envisioning a future where AI and clinical expertise on In Vitro Fertilization seamlessly collaborate to democratize access to medicine procedures, with a focus on assisted reproductive technologies. Our mission is to improve healthcare outcomes and transform lives through innovative solutions by devoloping of our solution EndoClassify.
EndoClassify is our Artificial Intelligence solution for Assisted Reproductive Technologies (ART), a two-tiered AI model using convolutional neural networks to determine the degree of endometrial receptivity, expressed as a percentage of a good or bad endometrium, as defined by our novel endometrial classification system.
For us, GenAI is not just a technological evolution, it's a strategic shift that demands a comprehensive understanding and alignment across organization executive levels.
We understand that embracing GenAI is not merely an option for leaders; it has become a strategic imperative for organizations aiming to thrive in this era of profound technological transformation.
We are committed to:
- Fostering a clear communication, shared objectives, and collective responsibility are paramount in the realms of digital product and technological transformation.
- Ensuring an effective top-tier IT organization aligned with AI initiatives and organizational strategies.
- Recognizing the transformative potential of AI and fosterign collaboration across disciplines are pivotal component of a strategic approach for organizations navigating the complexities of the technological landscape.
Introducing our groundbreaking new service in development phase dermatological analysis: leveraging cutting-edge neural network technology to predict and classify various skin conditions with unprecedented accuracy. Our innovative approach combines advanced machine learning algorithms with a vast dataset of dermatologic images to deliver precise and reliable predictions for a range of conditions, including nervus intradermico, queratosis seborreica, angioqueratoma, hemangioma, queratosis actinica, melanoma, carcinoma basocelular, and carcinoma epidermoide.
Powered by state-of-the-art neural networks trained on diverse and representative dermatological datasets, our service offers unparalleled insights into skin health and disease. By analyzing subtle patterns and features within dermatologic images, our models can accurately identify and classify different skin conditions, providing clinicians and healthcare professionals with invaluable diagnostic support and decision-making tools.
Introducing our innovative new service in the development phase: advanced mammography image analysis. Leveraging state-of-the-art artificial intelligence and machine learning technologies, we're pioneering a solution that aims to revolutionize breast cancer screening and diagnosis. Our cutting-edge approach combines deep learning algorithms with a vast repository of mammography images to provide accurate, efficient, and reliable analysis of breast health.
At the heart of our service is a sophisticated neural network architecture trained on diverse and annotated mammography datasets. This neural network is designed to detect and classify various abnormalities and lesions within mammograms, including masses, microcalcifications, architectural distortions, and more. By analyzing subtle patterns and features within mammography images, our models can assist radiologists and healthcare professionals in detecting early signs of breast cancer with unparalleled precision.
With our service in development, we're poised to transform breast cancer screening and diagnosis by harnessing the power of artificial intelligence and machine learning. By providing radiologists and healthcare professionals with advanced tools and insights, we aim to improve the early detection and treatment of breast cancer, ultimately saving lives and improving patient outcomes.
We specialize in helping enterprises optimize their performance through effective Key Performance Indicator (KPI) management. In today's fast-paced business environment, staying ahead of the competition requires more than just making informed decisions—it demands continuous monitoring, analysis, and adaptation to meet evolving objectives.
We understand the critical role that KPIs play in driving organizational success. That's why we've developed a comprehensive suite of services designed to empower enterprises to define, track, and optimize their key metrics with precision and confidence.
Our approach begins with a thorough assessment of your organization's unique goals, challenges, and operational landscape. Leveraging our expertise in KPI development and management, we work collaboratively with your team to identify the most relevant and impactful metrics for measuring performance across all aspects of your business—from sales and marketing to finance, operations, and beyond.
With our tailored KPI solutions, you'll gain actionable insights into your organization's performance in real-time, enabling you to make data-driven decisions with confidence and clarity. Whether you're seeking to improve operational efficiency, enhance customer satisfaction, or drive revenue growth, our KPI management services provide the strategic guidance and analytical tools you need to succeed.
Enhance your ART with the precision and reliability of Artificial Intelligence, utilizing a novel grading system that determines the receptivity of the endometrium
Start using the app in just a few easy steps.
All you need is an email account!
Manage your patients' ultrasound images along with the associated data on endometrial receptivity
A recent study published in the Journal of IVF-Worldwide presents the potential of a new model called “EndoClassify”, which is based on artificial intelligence (AI) and has been specifically developed to increase the chances of success of assisted reproductive technologies (ART). In these procedures, such as in vitro fertilization (IVF), the assessment of the uterine lining (endometrium) plays a crucial role, as the correct condition of the lining significantly influences the likelihood of a successful pregnancy.
A groundbreaking study published in the Journal of IVF-Worldwide unveils a novel artificial intelligence (AI) model that analyzes endometrial data to predict the success of assisted reproductive technology (ART). This research marks a significant advance in fertility medicine, offering new hope to couples struggling with infertility.
The innovative AI model was designed to analyze key endometrial features, providing a predictive assessment of the likelihood of successful implantation during ART procedures. By offering insights that previously required more invasive techniques or could only be inferred indirectly, this model helps clinicians tailor treatments to each patient's unique reproductive profile.
Nos encanta recibir a nuestros clientes, así que ven en cualquier momento durante las horas de oficina.
Abre hoy | 09:00 – 17:00 |
Usamos cookies para analizar el tráfico del sitio web y optimizar tu experiencia en el sitio. Al aceptar nuestro uso de cookies, tus datos se agruparán con los datos de todos los demás usuarios.